OTC Markets OTCPK - Delayed Quote USD

Spectral Medical Inc. (EDTXF)

0.7500 +0.0517 (+7.40%)

At close: November 2 at 9:40:25 AM EST

Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million of Maturing Convertible Notes

GlobeNewswire 18h ago

EDT.TO
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

GlobeNewswire 1mo ago

EDT.TO
Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire 2mo ago

EDT.TO
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

GlobeNewswire 4mo ago

EDT.TO

EDT.NE
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire 4mo ago

EDT.TO

EDT.NE
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

GlobeNewswire 4mo ago

EDT.TO

EDT.NE
Spectral Medical Submits PMX Premarket Approval Application to FDA

PREMIUM
MT Newswires 5mo ago

EDT.TO
Spectral Medical Announces PMA Submission to U.S. FDA for PMX

GlobeNewswire 5mo ago

EDT.TO

EDT.NE
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire 5mo ago

EDT.TO

EDT.NE
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference

TMX Newsfile 6mo ago

EDT.TO
Spectral Medical Swings to Q4 Loss

PREMIUM
MT Newswires 7mo ago

EDT.TO
Spectral Medical Inc. (TSE:EDT) Is Expected To Breakeven In The Near Future

Simply Wall St. 7mo ago

EDT.TO

U.S. markets open in 8h 20m

Spectral Medical Inc. (EDTXF)

Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million of Maturing Convertible Notes

Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Spectral Medical Submits PMX Premarket Approval Application to FDA

Spectral Medical Announces PMA Submission to U.S. FDA for PMX

Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update

Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference

Spectral Medical Swings to Q4 Loss

Spectral Medical Inc. (TSE:EDT) Is Expected To Breakeven In The Near Future